Summary
Updated Aug 31, 2026
Christopher Gibson is Director of RECURSION PHARMACEUTICALS, INC. (RXRX). 28 SEC Form 4 filings on record going back to 2024, most recently on 5 June 2026. Most recent open-market trade: sold $145K of RXRX on 5 June 2026. Lifetime open-market sales: $8.54M.
Recent Transactions
20Every recent SEC Form 4 transaction Christopher Gibson has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Christopher Gibson go back to 2024: 28 primary Form 4 filings, an average of 9.3 per year. 71 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Gibson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Blake Borgeson - $3.04M of RXRX open-market activity in the last 12 months
- Christian O. Henry - $771K of PACB open-market activity in the last 12 months
- Oene Mark van - $335K of PACB open-market activity in the last 12 months
- Najat Khan - $179K of RXRX open-market activity in the last 12 months
- James R. Gibson II - $121K of PACB open-market activity in the last 12 months
- Michele Farmer - $84K of PACB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Christopher Gibson?
Christopher Gibson is a corporate insider, tracked as Director of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 28 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher Gibson submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Christopher Gibson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 26 open-market sales ($8.54M) across all tracked filings.
Where can I see all of Christopher Gibson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Christopher Gibson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial